Pandemic Timeline

Wichita State University files patent US20120265001: Composite magnetic nanoparticle drug delivery system

A composite magnetic nanoparticle drug delivery system provides targeted controlled release chemotherapies for cancerous tumors and inflammatory diseases. The magnetic nanoparticle includes a biocompatible and biodegradable polymer, a magnetic nanoparticle, the biological targeting agent human serum albumin, and a therapeutic pharmaceutical composition. The composite nanoparticles are prepared by oil-in-oil emulsion/solvent evaporation and high shear mixing. An externally applied magnetic field draws the magnetic nanoparticles to affected areas. The biological targeting agent draws the nanoparticles into the affected tissues. Polymer degradation provides controlled time release delivery of the pharmaceutical agent.

Patent US20120265001A1

[This patent] discusses composite magnetic nanoparticles for a drug delivery system. This brings light to what many microscopists worldwide have been discovering in looking at vials under the microscope, they are seeing all these nanoparticles that reflect light and these are literally magnetic nanoparticles, originally developed for delivery of chemotherapy agents to targeted organs (for example the organ affected by cancer).

— Karen Kingston via Knowing The Truth

Sources:

See also, on this site:

 

 

 

Comments are closed.